Key result
Impaired MFR on 82Rb PET predicts ~230% greater risk of hard cardiac events.
Why the study?
The clinical value of myocardial flow reserve quantification using rubidium-82 positron emission tomography beyond relative myocardial perfusion imaging remained uncertain.
Does myocardial flow reserve (MFR) quantification using 82Rb PET predict adverse outcomes in patients assessed for myocardial ischemia?
Population
704 consecutive patients assessed for ischemia
Comparison
Stratification across 4 groups based on normal or abnormal SSS and MFR
Design
Prospective cohort study
Follow-up
Median 387 days
Authors
Loading...
May enhance risk stratification in suspected ischemia; leaves open whether it guides therapy decisions.
Cohort (n=704)
Does myocardial flow reserve (MFR) quantification using 82Rb PET predict adverse outcomes in patients assessed for myocardial ischemia?
Hazard Ratio: 3.3 (95% CI 1.1–9.5)
p-value: p=0.029
MFR quantified using 82Rb PET provides incremental prognostic value over relative myocardial perfusion imaging for predicting hard cardiac events and MACE.
Ziadi et al. (2011) conducted a cohort in Myocardial ischemia (n=704). Impaired myocardial flow reserve (MFR < 2) vs. Normal myocardial flow reserve (MFR ≥ 2) was evaluated on Hard events (cardiac death and myocardial infarction) (HR 3.3, 95% CI 1.1-9.5, p=0.029). Impaired myocardial flow reserve (MFR <2) on 82Rb PET independently predicted hard cardiac events (HR 3.3; 95% CI 1.1-9.5; p=0.029) in patients assessed for ischemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: